BERRY v. UNITED STATES OF AMERICA

CourtDistrict Court, D. New Jersey
DecidedDecember 7, 2022
Docket1:22-cv-06113
StatusUnknown

This text of BERRY v. UNITED STATES OF AMERICA (BERRY v. UNITED STATES OF AMERICA) is published on Counsel Stack Legal Research, covering District Court, D. New Jersey primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
BERRY v. UNITED STATES OF AMERICA, (D.N.J. 2022).

Opinion

NOT FOR PUBLICATION

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW JERSEY CAMDEN VICINAGE ______________________________

GREGORY MAC DONALD : BERRY, : : Civ. No. 22-6113 (RMB-AMD) Plaintiff. : : v. : : OPINION UNITED STATES OF AMERICA, : et al., : : Defendants. : ______________________________ :

RENÉE MARIE BUMB, United States District Judge Plaintiff Gregory Mac Donald Berry, a federal prisoner incarcerated in the Federal Correctional Institution in Fairton, New Jersey ("FCI Fairton"), filed this civil suit under 42 U.S.C. § 1983, alleging medical malpractice and deliberate indifference to his serious medical needs while incarcerated in various federal prisons, most recently in FCI Fairton. Plaintiff paid the filing fee but submitted an IFP application (IFP App., Docket No. 1-1) under 28 U.S.C. § 1915(a), for the purpose of obtaining service of the summons and complaint on the defendants by the United States Marshals Service. Although Plaintiff submitted a statement of his inmate trust account, it is not a certified statement signed by the appropriate prison official, as required under 28 U.S.C. § 1915(a)(2). Therefore, his IFP application will be denied without prejudice. For the reasons, discussed below, Plaintiff's complaint may proceed in part and will be dismissed in part, with leave to file an amended complaint, if he can allege additional facts supporting those claims that are dismissed

without prejudice. I. SUA SPONTE DISMISSAL When a prisoner files a complaint and brings claims against a governmental entity or officer or employee of a governmental entity, 28 U.S.C. § 1915A(b) or

brings claims concerning prison conditions, 42 U.S.C. § 1997e(c)(1), courts must review the complaint and sua sponte dismiss any claims that are: (1) frivolous or malicious; (2) fail to state a claim on which relief may be granted; or (3) seek monetary relief against a defendant who is immune from such relief. Courts, however, must liberally construe pleadings that are filed pro se. Erickson v. Pardus,

551 U.S. 89, 94 (2007). The legal standard for dismissing a complaint for failure to state a claim pursuant to 28 U.S.C. § 1915(e)(2)(B)(ii) is the same as that for dismissal under Federal Rule of Civil Procedure 12(b)(6). See, Schreane v. Seana, 506 F. App’x 120, 122 (3d Cir. 2012). “To survive a motion to dismiss, a complaint must contain sufficient factual matter, accepted as true, to ‘state a claim to relief that is

plausible on its face.’” Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009) (quoting Bell Atlantic Corp. v. Twombly, 550 U.S. 544, 570 (2007)). “A claim has facial plausibility when the plaintiff pleads factual content that allows the court to draw the reasonable inference that the defendant is liable for the misconduct alleged.” Id. (quoting Twombly, 550 U.S. at 556.) This Court will screen the complaint and will then consider, pursuant to Federal Rule of Civil Procedure 21, whether the claims and defendants are properly joined under Federal Rules of Civil Procedure 18 and 20. II. THE COMPLAINT

Plaintiff asserts jurisdiction under the Federal Tort Claims Act, 28 U.S.C. § 1346(b) and Bivens v. Six Unknown Named Agents of Federal Bureau of Narcotics, 403 U.S. 388 (1971). The defendant to the FTCA claim is the United States of America, and the defendants to the Bivens claims, in their individual and official capacities, are

RN C. Hansen, Dr. Abigail Lopez De LaSalle, D.O. Ellen Mace-Leibson, and ARNP Camilla Hansen. Plaintiff seeks damages and declaratory and injunctive relief against the United States of America for medical malpractice under the Federal Tort Claims Act, and also against the individual defendants under Bivens for deliberate

indifference to his serious medical needs. Plaintiff was incarcerated in various correctional institutions within the Federal Bureau of Prisons from at least 2011 to the present. He was transferred to FCI Fairton in October 2018. After Plaintiff was diagnosed with Stage III kidney disease in 2014. He was advised to avoid taking NSAIDS. However, he was prescribed NSAIDS to treat his

chronic pain for 61 out of 99 months during his incarceration within the Federal Bureau of Prisons ("BOP") in Indiana, Arizona and New Jersey. He alleges medical malpractice for prescribing him medication that worsened his kidney disease. In August 2012, Plaintiff was diagnosed with reflux esophagitis ("GERD"). Over the next three years at USP Tuscon, his treatment with omeprazole controlled his severe GERD symptoms. After he was transferred to Terre Haute, Indiana, he was treated in the chronic care clinic with omeprazole. After he was transferred to FCI Fairton, on October 10, 2018, Dr. Lopez discontinued his prescription for

omeprazole and removed him from the chronic care clinic, advising him instead to purchase ranitidine from the commissary. One day later, and through May 19, 2021, Plaintiff was placed back in the chronic care clinic and supplied with omeprazole, but only when the medication was not available for his purchase in the commissary. On December 23, 2020, a physician's assistant documented that omeprazole

was clinically indicated for Plaintiff's treatment. That same day, D.O. Mace-Leibson signed a discontinuation of Plaintiff's prescription for omeprazole, based on the pharmacist's note that he did not qualify for a prescription. He was advised to purchase omeprazole at the commissary. After May 2021, when Plaintiff requested omeprazole from RN C. Hansen when it out-of-stock in the commissary, she refused

and told him to buy Tums and Mylanta. Without omeprazole, Plaintiff suffers pain from GERD. Further, he alleges his use of omeprazole requires monitoring in the chronic care clinic because omeprazole has potential for kidney toxicity. In addition to a medical malpractice claim, he alleges Dr. Lopez, D.O. Mace-Leibson, and RN C. Hansen were deliberately indifferent to his serious medical needs, in violation of

the Eighth Amendment. Plaintiff also suffered from a lactose intolerance, which was noted in his medical records on January 19, 2011. He was approved for a lactose-free diet, but he allowed this to lapse. Years later, in 2017, he requested an evaluation for a wheat allergy, reporting that when he eliminated wheat from his diet his bowel symptoms disappeared. Staff in Health Services advised him that his test results did not support a food allergy, but he could continue to self-select gluten-free food if it alleviated his

symptoms.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Estelle v. Gamble
429 U.S. 97 (Supreme Court, 1976)
Carlson v. Green
446 U.S. 14 (Supreme Court, 1980)
Erickson v. Pardus
551 U.S. 89 (Supreme Court, 2007)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Raymond Hughes v. United States
263 F.3d 272 (Third Circuit, 2001)
Clarence Schreane v. Seana
506 F. App'x 120 (Third Circuit, 2012)
Roma v. United States
344 F.3d 352 (Third Circuit, 2003)
Ronald Greenland v. United States
661 F. App'x 210 (Third Circuit, 2016)
Priovolos v. Federal Bureau of Investigation
686 F. App'x 150 (Third Circuit, 2017)
Ziglar v. Abbasi
582 U.S. 120 (Supreme Court, 2017)
Brown v. Borough of Chambersburg
903 F.2d 274 (Third Circuit, 1990)

Cite This Page — Counsel Stack

Bluebook (online)
BERRY v. UNITED STATES OF AMERICA, Counsel Stack Legal Research, https://law.counselstack.com/opinion/berry-v-united-states-of-america-njd-2022.